AI MARKET SCANNING

Allogene Therapeutics, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +3.07%
MAX GAP RECORD +12.07%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ALLO
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+2.90%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
-1.29%
Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE)
+3.64%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+0.00%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
+0.96%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-2.65%
Mar 13, 2025 Earnings Release 2025-03-13 (AFTER CLOSE)
+7.41%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
+1.57%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.8%
Bullish Gaps (9)
Bearish Gaps (3)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ALLO

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗